Taal:
Valuta:
0 ARTIKELEN - $0.00 Bonus: 2
Generic Velpanat
Velpanat
Velpanat is an antiviral combination of sofosbuvir and velpatasvir used to treat chronic hepatitis C virus (HCV) infection across all major genotypes.
Selecteer Doses: 400/100mg
400/100mg
28tabs
Velpanat $1663.19
$1385.99
$49.50 per tab
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
Toevoegen aan winkelwagentje
bespaar: $0.00
400/100mg
56tabs
Velpanat $3144.95
$2620.79
$46.80 per tab
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
Toevoegen aan winkelwagentje
bespaar: $151.20
Package Example
Je bestelling wordt veilig verpakt en binnen 24 uur verzonden. Dit is precies hoe je pakket eruit zal zien (foto's van een echt verzendstuk). Het heeft de afmetingen en het uiterlijk van een gewone particuliere brief (9,4x4,3x0,3 inch of 24x11x0,7 cm) en geeft de inhoud niet prijs
Levertijd
Levering 14-21 dagen 10$ Tracking# beschikbaar in 4 dagen
Gratis standaard luchtpost voor alle bestellingen met een bedrag vanaf $200
Levering 5-9 dagen 30$ Tracking# beschikbaar in 2 dagen
Gratis traceerbare koeriersdienst voor alle bestellingen vanaf $300
Wereldwijde verzending Vertrouwelijkheid en anonimiteit gegarandeerd
Veilig en zeker Discreet looking packages
Bestellingen worden binnen 24 uur verzonden 100% succesvolle levering
Getuigenissen Productbeschrijving
Er is op dit moment geen beoordeling voor dit product, maar je kunt de eerste zijn om iets toe te voegen of je kunt meer lezen in Testimonials over gerelateerde producten.

Beoordeling Toevoegen

Common use

Velpanat is prescribed for the treatment of chronic hepatitis C in adults. The combination of sofosbuvir (a nucleotide polymerase inhibitor) and velpatasvir (an NS5A inhibitor) works by blocking the virus’s ability to replicate and spread in the body, leading to viral clearance when taken as directed.

Dosage and direction

Velpanat is taken once daily, with or without food. Tablets should be swallowed whole. Treatment duration is typically 12 weeks but may vary depending on hepatitis C genotype, liver condition, or prior therapy. Follow your healthcare provider’s instructions carefully.

Precautions

Inform your doctor if you have a history of liver failure, hepatitis B infection, kidney disease, or if you take medications for heart rhythm issues. Patients co-infected with HBV and HCV may be at risk of HBV reactivation. Do not stop treatment without consulting your doctor.

Contraindications

Velpanat is contraindicated in individuals with known hypersensitivity to sofosbuvir, velpatasvir, or any tablet components. It should not be used with certain medications that significantly reduce velpatasvir levels.

Possible side effect

Common side effects include headache, fatigue, nausea, and insomnia. Less common but serious effects may include slow heartbeat (especially if taken with amiodarone), liver function changes, or allergic reactions. Seek medical attention for severe or unusual symptoms.

Drug interaction

Velpanat may interact with antacids, proton pump inhibitors, rifampicin, St. John’s Wort, certain anticonvulsants, and HIV medications. Some interactions may reduce effectiveness. Always inform your healthcare provider of all medications and supplements you take.

Missed dose

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one. Do not double the dose.

Overdose

Overdose may cause severe headache, fatigue, nausea, or general discomfort. Seek medical attention immediately if an overdose is suspected.

Storage

Store Velpanat at room temperature, away from moisture, heat, and direct sunlight. Keep it in its original bottle and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Getuigenissen
Barbara Smith, Ansonia, United States
I AM SO SORRY TO HAVE DOUBTED YOUR SERVICE. I RECEIVED A NOTICE FROM THE POST OFFICE ON FRIDAY 11/4, THAT A REG. MAIL FROM YOU WAS THERE. I WILL BE RECEIVING THE PACKAGE TODAY. THANK YOU SO MUCH FOR ALL YOUR ASSISTANCE AND AGAIN I APOLOGIZE FOR NOT HAVING ...
Geoffrey Stidworthy, EAST MELBOURNE, Australia
My apologies. I did not know the items were sent separately. I received the second envelope yesterday. Thank you for your help and support. Have a great day.
Jerry, 57, Munich
“We were at the edge of divorce when I decided to try this. Years and years without delight of orgasm and sexual satisfaction. This could ruin any life but not ours. Viagra worked and I always keep the pill near my bed as nobody knows when my wife asks ...
Meer lezen...

Verzendoptie

Veilig Betalingsproces
Nieuws
Women with PMOS should have yearly NHS checks, says health watchdog
Despite affecting millions of women in the UK, PMOS is still under-diagnosed and inconsistently managed, say experts.
'Normal birth drive' criticism removed from maternity report, expert claims
Dr Bill Kirkup says he resigned from a government-commissioned review into NHS maternity services over the omission.
Government promises to act on maternity care failings which 'shame our society'
An independent inquiry has found "unacceptable racism and discrimination" is affecting patient safety.
Resident doctors in England accept pay deal and end strikes
Doctors have been locked in a three-year dispute with the government, resulting in several rounds of strikes.